172 related articles for article (PubMed ID: 37568795)
1. Influence of the Hypersensitivity to Low Dose Phenomenon on the Tumor Response to Hypofractionated Stereotactic Body Radiation Therapy.
Le Reun E; Granzotto A; Pêtre A; Bodgi L; Beldjoudi G; Lacornerie T; Vallet V; Bouchet A; Al-Choboq J; Bourguignon M; Thariat J; Bourhis J; Lartigau E; Foray N
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568795
[TBL] [Abstract][Full Text] [Related]
2. Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer.
Royce TJ; Mavroidis P; Wang K; Falchook AD; Sheets NC; Fuller DB; Collins SP; El Naqa I; Song DY; Ding GX; Nahum AE; Jackson A; Grimm J; Yorke E; Chen RC
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):227-236. PubMed ID: 32900561
[TBL] [Abstract][Full Text] [Related]
3. A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.
Kole TP; Nichols RC; Lei S; Wu B; Huh SN; Morris CG; Lee S; Tong M; Mendenhall NP; Dritschilo A; Collins SP
Acta Oncol; 2015 Jun; 54(6):825-31. PubMed ID: 25227898
[TBL] [Abstract][Full Text] [Related]
4. [Very low-dose hyper-radiosensitivity: impact for radiotherapy of micrometastases].
Thomas C; Fertil B; Foray N
Cancer Radiother; 2007 Sep; 11(5):260-5. PubMed ID: 17683966
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control.
Stinauer MA; Kavanagh BD; Schefter TE; Gonzalez R; Flaig T; Lewis K; Robinson W; Chidel M; Glode M; Raben D
Radiat Oncol; 2011 Apr; 6():34. PubMed ID: 21477295
[TBL] [Abstract][Full Text] [Related]
6. Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer.
Mahadevan A; Moningi S; Grimm J; Li XA; Forster KM; Palta M; Prior P; Goodman KA; Narang A; Heron DE; Lo SS; Urbanic J; Herman JM
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):206-216. PubMed ID: 33358561
[TBL] [Abstract][Full Text] [Related]
7. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
[TBL] [Abstract][Full Text] [Related]
8. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
[TBL] [Abstract][Full Text] [Related]
9. The radiobiological targets of SBRT: tumor cells or endothelial cells?
Karam SD; Bhatia S
Ann Transl Med; 2015 Nov; 3(19):290. PubMed ID: 26697450
[TBL] [Abstract][Full Text] [Related]
10. Post radiation mucosal ulcer risk after a hypofractionated stereotactic boost and conventional fractionated radiotherapy for oropharyngeal carcinoma.
Verduijn GM; Petit SF; Lauwers I; van Norden Y; Sijtsema ND; Sewnaik A; Mast H; Capala M; Nout R; Baker S; van Meerten E; Hoogeman MS; van der Lugt A; Heemsbergen WD
Acta Oncol; 2023 Jan; 62(1):40-47. PubMed ID: 36576773
[TBL] [Abstract][Full Text] [Related]
11. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?
Brown JM; Carlson DJ; Brenner DJ
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):254-62. PubMed ID: 24411596
[TBL] [Abstract][Full Text] [Related]
12. Chemopotentiating effects of low-dose fractionated radiation on cisplatin and paclitaxel in cervix cancer cell lines and normal fibroblasts from patients with cervix cancer.
Słonina D; Kabat D; Biesaga B; Janecka-Widła A; Szatkowski W
DNA Repair (Amst); 2021 Jul; 103():103113. PubMed ID: 33839463
[TBL] [Abstract][Full Text] [Related]
13. Forcing lateral electron disequilibrium to spare lung tissue: a novel technique for stereotactic body radiation therapy of lung cancer.
Disher B; Hajdok G; Gaede S; Mulligan M; Battista JJ
Phys Med Biol; 2013 Oct; 58(19):6641-62. PubMed ID: 24018569
[TBL] [Abstract][Full Text] [Related]
14. Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy.
Prasanna A; Ahmed MM; Mohiuddin M; Coleman CN
J Thorac Dis; 2014 Apr; 6(4):287-302. PubMed ID: 24688774
[TBL] [Abstract][Full Text] [Related]
15. Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy.
Wei S; Lin H; Shi C; Xiong W; Chen CC; Huang S; Press RH; Hasan S; Chhabra AM; Choi JI; Simone CB; Kang M
Med Phys; 2022 Oct; 49(10):6560-6574. PubMed ID: 35929404
[TBL] [Abstract][Full Text] [Related]
16. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
17. Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation.
Repka MC; Aghdam N; Kataria SK; Campbell L; Suy S; Collins SP; Anderson E; Lischalk JW; Collins BT
Radiat Oncol; 2017 Oct; 12(1):162. PubMed ID: 29052514
[TBL] [Abstract][Full Text] [Related]
18. Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy.
Sahgal A; Chang JH; Ma L; Marks LB; Milano MT; Medin P; Niemierko A; Soltys SG; Tomé WA; Wong CS; Yorke E; Grimm J; Jackson A
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):124-136. PubMed ID: 31606528
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer.
Oermann EK; Slack RS; Hanscom HN; Lei S; Suy S; Park HU; Kim JS; Sherer BA; Collins BT; Satinsky AN; Harter KW; Batipps GP; Constantinople NL; Dejter SW; Maxted WC; Regan JB; Pahira JJ; McGeagh KG; Jha RC; Dawson NA; Dritschilo A; Lynch JH; Collins SP
Technol Cancer Res Treat; 2010 Oct; 9(5):453-62. PubMed ID: 20815416
[TBL] [Abstract][Full Text] [Related]
20. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
